|
MYO1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.018100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.784180E-03 |
| Normal-vs-Stage2 |
8.590000E-01 |
| Normal-vs-Stage3 |
5.117000E-01 |
| Normal-vs-Stage4 |
7.414400E-01 |
| Stage1-vs-Stage2 |
3.635900E-02 |
| Stage1-vs-Stage3 |
5.797900E-02 |
| Stage1-vs-Stage4 |
2.917900E-03 |
| Stage2-vs-Stage3 |
5.439400E-01 |
| Stage2-vs-Stage4 |
9.726800E-01 |
| Stage3-vs-Stage4 |
3.841200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.944460E-02 |
| Normal-vs-AfricanAmerican |
1.858050E-01 |
| Normal-vs-Asian |
5.870200E-01 |
| Caucasian-vs-AfricanAmerican |
9.039300E-03 |
| Caucasian-vs-Asian |
8.445600E-01 |
| AfricanAmerican-vs-Asian |
2.116600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.370610E-01 |
| Normal-vs-Female |
5.040100E-02 |
| Male-vs-Female |
5.116200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.532200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.989700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.693580E-01 |
| Normal-vs-Age(81-100Yrs) |
9.437600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.311600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.403800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.284400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.697600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.084000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.468000E-02 |
| Normal-vs-Grade 2 |
1.953230E-04 |
| Normal-vs-Grade 3 |
6.242400E-01 |
| Normal-vs-Grade 4 |
6.690400E-01 |
| Grade 1-vs-Grade 2 |
4.768800E-01 |
| Grade 1-vs-Grade 3 |
7.587600E-02 |
| Grade 1-vs-Grade 4 |
7.680100E-02 |
| Grade 2-vs-Grade 3 |
3.98560000003378E-06 |
| Grade 2-vs-Grade 4 |
5.610600E-04 |
| Grade 3-vs-Grade 4 |
9.415800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.823900E-04 |
| Normal-vs-ccB subtype |
2.481000E-01 |
| ccA subtype-vs-ccB subtype |
4.831800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.937780E-01 |
| Normal-vs-N1 |
3.366600E-01 |
| N0-vs-N1 |
2.116600E-01 |
|
|
